“…Importantly, TSP-1 can inhibit endothelial nitric oxide synthase (eNOS) activation and thus reduce NO production (Isenberg, Martin-Manso, Maxhimer, & Roberts, 2009). Furthermore, TSP-1 has a direct role in mediating immune infiltration (Mandler, Nurkiewicz, Porter, & Olfert, 2017), a key source of tissue inflammation. However, TSP-1 expression can also be mediated by TNF signalling (Fairaq, Goc, Artham, Sabbineni, & Somanath, 2015), suggesting a role for TNF mediating TSP-1 production as a potential mechanism of tPVATmediated aortic dysfunction in MetS.…”